|
May 19
|
Oncology Institute And 2 Other Promising Penny Stocks To Watch
|
|
May 16
|
Oncology Institute First Quarter 2025 Earnings: US$0.25 loss per share (vs US$0.22 loss in 1Q 2024)
|
|
May 14
|
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance
|
|
May 14
|
The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer
|
|
May 13
|
The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference
|
|
Sep 30
|
The Oncology Institute of Hope & Innovation Launches Oregon Market
|
|
Dec 20
|
Insider Spends US$127k Buying More Shares In Oncology Institute
|
|
Dec 4
|
The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in California
|
|
Nov 10
|
Even With A 49% Surge, Cautious Investors Are Not Rewarding The Oncology Institute, Inc.'s (NASDAQ:TOI) Performance Completely
|
|
Nov 8
|
The Oncology Institute Inc (TOI) Reports Q3 2023 Results: Revenue Up, Net Loss Widens
|
|
Nov 8
|
The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance
|
|
Nov 7
|
Oncology Institute Decline Means Insider Profits Down To US$113k
|
|
Aug 9
|
Ambience Healthcare and The Oncology Institute (TOI) Partner to Create a Best-in-Class Oncology Experience for Patients and Clinicians, Leveraging Breakthrough Generative AI Technology
|
|
Aug 8
|
The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance
|